Several major grocers are taking on an Israeli pharmaceutical company, and its subsidiaries, saying the drug maker is allegedly illegally hindering generic competitors and driving up prices for their own gain. The folks impacted: Patients with relapsing multiple sclerosis symptoms.
A lawsuit has been pending in New Jersey for about three years accusing Teva Pharmaceuticals and its many related companies of monopolizing a drug that reduces relapsing symptoms in patients with multiple sclerosis. Texas’ favorite grocer, H-E-B , alongside Walgreens, Kroger and Albertsons, filed a separate suit in Vermont essentially arguing the same thing. MySA reached out H-E-B, Walgreens, Kroger and Albertsons for comment.
“Despite the availability of these more affordable generic Copaxone products, Teva continued to dominate the market by unlawfully suppressing generic competition to branded Copaxone,” the lawsuit alleges, claiming the Israeli company employed unethical practices to rake in $3 billion in profit and quash its competition…